Galderma Group N
Swiss Stock Exchange GALD.SW
Galderma Group N EBIT for the year ending December 31, 2023: USD 607.18 M
Galderma Group N EBIT is USD 607.18 M for the year ending December 31, 2023, a 71.70% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
Galderma Group N EBIT for the year ending December 31, 2022 was USD 353.63 M, a 30.12% change year over year.
-
Galderma Group N EBIT for the year ending December 31, 2021 was USD 271.78 M.
Key data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Market news
Loading...
Swiss Stock Exchange: GALD.SW
| CEO | Dr. Flemming Ornskov M.B.A., M.P.H. |
| IPO Date | March 21, 2024 |
| Location | Switzerland |
| Headquarters | Zählerweg 10 |
| Employees | 6,545 |
| Sector | Consumer Discretionary |
| Industries | |
Description
Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email